These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10442690)

  • 1. Some international approaches to aminoglycoside monitoring in the extended dosing interval era.
    Morris RG; Sallustio BC; Vinks AA; LeGatt DF; Verjee ZH; El Desoky E
    Ther Drug Monit; 1999 Aug; 21(4):379-88. PubMed ID: 10442690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-interval dosing of aminoglycosides.
    Blam ME; Hammer GS
    Mt Sinai J Med; 1997 Nov; 64(6):386-91. PubMed ID: 9364833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended interval aminoglycoside dosing: from concept to clinic.
    Maglio D; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2002 Apr; 19(4):341-8. PubMed ID: 11978505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoeconomic evaluation of once-daily aminoglycoside treatment.
    Periti P
    J Chemother; 1995 Aug; 7(4):380-94. PubMed ID: 8568549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
    Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum monitoring and practicalities of once-daily aminoglycoside dosing.
    O'Shaughnessy EM; Das SS
    J Antimicrob Chemother; 1994 Feb; 33(2):350-1; author reply 351-2. PubMed ID: 8182019
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglycoside dosage regimens after therapeutic drug monitoring.
    Kirkpatrick CM; Begg EJ; Barclay ML; Duffull SB
    Clin Pharmacokinet; 2002; 41(10):791-2. PubMed ID: 12162762
    [No Abstract]   [Full Text] [Related]  

  • 15. Aminoglycoside dosing in diabetes.
    Axworthy S; Gardner D
    J Clin Pharm Ther; 2000 Apr; 25(2):81-4. PubMed ID: 10849185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily aminoglycosides in the treatment of gram-positive endocarditis.
    Tam VH; Preston SL; Briceland LL
    Ann Pharmacother; 1999 May; 33(5):600-6. PubMed ID: 10369625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving aminoglycoside dosing through computerized clinical decision support and pharmacy therapeutic monitoring systems.
    Phillips IE; Nelsen C; Peterson J; Sullivan TM; Waitman LR
    AMIA Annu Symp Proc; 2008 Nov; ():1093. PubMed ID: 18999099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenging conventional aminoglycoside dosing regimens. The value of experimental models.
    Kapusnik JE; Sande MA
    Am J Med; 1986 Jun; 80(6B):179-81. PubMed ID: 3089001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity.
    Avent ML; Rogers BA; Cheng AC; Paterson DL
    Intern Med J; 2011 Jun; 41(6):441-9. PubMed ID: 21309997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.